Page last updated: 2024-08-23

clavulanic acid and avibactam

clavulanic acid has been researched along with avibactam in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (75.00)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Black, MT; Bruneau, JM; Claudon, M; Coleman, K; Frère, JM; Miossec, C; Péchereau, MC; Stachyra, T1
Benvenuti, M; Burns, CJ; Chu, GH; Cusick, SM; Daigle, DM; De Luca, F; Docquier, JD; Hamrick, JC; Jackson, RW; Liu, B; Mangani, S; McGarry, D; Pevear, DC; Pozzi, C; Trout, REL; Weiss, WJ; Xerri, L1
Baumert, P; Feihl, S; Gastmeier, P; Gebhardt, F; Gölz, H; Hamprecht, A; Kern, WV; Knobloch, J; Kola, A; Mischnik, A; Obermann, B; Peter, S; Querbach, C; Rohde, A; Seifert, H; Tacconelli, E; Willmann, M1
Arthur, M; Compain, F; Dubée, V; Fichini, M; Hugonnet, JE; Mainardi, JL; Ourghanlian, C; Soroka, D1
Arthur, M; Ourghanlian, C; Soroka, D1
Amicosante, G; Conte, V; Giani, T; Perilli, M; Piccirilli, A; Rossolini, GM; Tascini, C1
Blok, A; Pannu, NS; Tassoni, R; Ubbink, M1
Blok, AJ; Elings, W; Gaur, A; Timmer, M; Ubbink, M; van Ingen, H1

Other Studies

8 other study(ies) available for clavulanic acid and avibactam

ArticleYear
Mechanistic studies of the inactivation of TEM-1 and P99 by NXL104, a novel non-beta-lactam beta-lactamase inhibitor.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Inhibitory Concentration 50; Molecular Structure; Spectrometry, Mass, Electrospray Ionization

2010
Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections.
    Journal of medicinal chemistry, 2020, 03-26, Volume: 63, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; Borinic Acids; Carbapenems; Carboxylic Acids; Humans; Mice; Models, Molecular

2020
Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
    International journal of antimicrobial agents, 2017, Volume: 49, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; Cephalosporin Resistance; Cephalosporins; Clavulanic Acid; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Germany; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Tazobactam; Young Adult

2017
Inhibition of β-lactamases of mycobacteria by avibactam and clavulanate.
    The Journal of antimicrobial chemotherapy, 2017, 04-01, Volume: 72, Issue:4

    Topics: Amino Acid Substitution; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Enzyme Stability; Escherichia coli; Mass Spectrometry; Mutant Proteins; Mycobacterium

2017
Inhibition by Avibactam and Clavulanate of the β-Lactamases KPC-2 and CTX-M-15 Harboring the Substitution N
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:3

    Topics: Amino Acid Motifs; Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftaroline; Ceftazidime; Cephalosporins; Clavulanic Acid; Cloning, Molecular; Drug Combinations; Escherichia coli; Gene Expression; Kinetics; Mutation; Recombinant Proteins; Reverse Genetics; Substrate Specificity

2017
TEM-184, a Novel TEM-Derived Extended-Spectrum β-Lactamase with Enhanced Activity against Aztreonam.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:9

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Escherichia coli; Humans; Kinetics; Microbial Sensitivity Tests; Sequence Alignment; Tazobactam

2018
New Conformations of Acylation Adducts of Inhibitors of β-Lactamase from Mycobacterium tuberculosis.
    Biochemistry, 2019, 02-19, Volume: 58, Issue:7

    Topics: Acylation; Aldehydes; Amino Acid Substitution; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Catalytic Domain; Clavulanic Acid; Crystallography, X-Ray; Mycobacterium tuberculosis; Protein Conformation; Serine; Sulbactam; Tazobactam

2019
β-Lactamase of Mycobacterium tuberculosis Shows Dynamics in the Active Site That Increase upon Inhibitor Binding.
    Antimicrobial agents and chemotherapy, 2020, 02-21, Volume: 64, Issue:3

    Topics: Azabicyclo Compounds; beta-Lactamases; Boronic Acids; Catalytic Domain; Clavulanic Acid; Magnetic Resonance Spectroscopy; Mycobacterium tuberculosis; Protein Binding

2020